Home›Trial›NCT05170425
🔬NCT05170425ACTIVE NOT RECRUITING

LAMBDA 002 (Lung Registry) Study

Study Summary

The LAMBDA 002 registry study is an observational, longitudinal, multi-center study observing patients undergoing lung transplant.

Conditions
Lung Transplant Rejection
Interventions / Drugs
Prospera
View on ClinicalTrials.gov ↗
Sponsor
NTRA
Natera Inc
Genetics Diagnostics
D48/100
Study Details
Enrollment154 participants
Primary Completion—
Lead SponsorNatera, Inc.
Data Retrieved2026-04-11 04:23:02.260821+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.